Ness Ziona, Israel, 29.01.2020 (PresseBox) – ISRAC notified Analyst Research Laboratories that it has successfully passed its latest audit, and has been rewarded with an extension of its GCLP certification.
Analyst’s CEO, Dr. Vivi Ziv commented: “Analyst was the first laboratory in Israel to receive GCLP accreditation, which relates to the analyses of human samples from clinical trials. Clinical trials are probably the most expensive stage in the development of a pharmaceutical. As such, the handling and analysis of each sample collected is critical for the decision-making process of a company. As a top-quality service lab, we are constantly honored with the trust our clients give us by placing these precious samples for analysis in our lab.”
ISRAC is the designated representative of the State of Israel for the recognition of test facilities working; according to GLP. The state of Israel has a mutual recognition agreement regarding GLP with the European community and the OECD, thus ensuring mutual recognition from signatory countries to these agreements.
Please find Analyst’s certification document > here
About Analyst Research Laboratories
Analyst Research Laboratories is a GMP, GLP and GCLP accredited, FDA-inspected contract laboratory. The 1,000sqm modern lab specializes in all aspects of analyzing pharmaceuticals, providing a multitude of Analytical & Bioanalytical services to the pharmaceutical, medical cannabis, biotech and medical device industries. Please visit Analyst’s website for further information at https://www.analyst-labs.com
Unternehmen: Tentamus Group GmbH
Den Originalartikel finden Sie auf www.pressebox.de